全文获取类型
收费全文 | 1042篇 |
免费 | 61篇 |
国内免费 | 8篇 |
专业分类
耳鼻咽喉 | 25篇 |
儿科学 | 19篇 |
妇产科学 | 18篇 |
基础医学 | 88篇 |
口腔科学 | 18篇 |
临床医学 | 88篇 |
内科学 | 163篇 |
皮肤病学 | 31篇 |
神经病学 | 96篇 |
特种医学 | 78篇 |
外科学 | 238篇 |
综合类 | 10篇 |
一般理论 | 1篇 |
预防医学 | 40篇 |
眼科学 | 10篇 |
药学 | 85篇 |
中国医学 | 2篇 |
肿瘤学 | 101篇 |
出版年
2023年 | 11篇 |
2022年 | 18篇 |
2021年 | 43篇 |
2020年 | 27篇 |
2019年 | 32篇 |
2018年 | 38篇 |
2017年 | 46篇 |
2016年 | 50篇 |
2015年 | 57篇 |
2014年 | 67篇 |
2013年 | 62篇 |
2012年 | 101篇 |
2011年 | 107篇 |
2010年 | 49篇 |
2009年 | 52篇 |
2008年 | 59篇 |
2007年 | 68篇 |
2006年 | 55篇 |
2005年 | 61篇 |
2004年 | 35篇 |
2003年 | 24篇 |
2002年 | 31篇 |
2001年 | 5篇 |
2000年 | 2篇 |
1999年 | 1篇 |
1998年 | 1篇 |
1997年 | 4篇 |
1996年 | 2篇 |
1992年 | 2篇 |
1974年 | 1篇 |
排序方式: 共有1111条查询结果,搜索用时 15 毫秒
21.
Mostafa Jafari Thanh N. Nguyen Santiago Ortega-Gutierrez Muhammad Shazam Hussain Ameer E. Hassan Asad Ikram Javed Khader Eliyas Gustavo J. Rodriguez Afshin A. Divani 《Journal of stroke and cerebrovascular diseases》2021,30(3):105556
Objectives/BackgroundMedical therapy is the first line of treatment for intracranial atherosclerotic disease (ICAD). Percutaneous transluminal angioplasty and stenting (PTAS) are mainly considered for those patients with severe stenosis and recurrent events despite aggressive medical therapy. In this review, we discuss the application of PTAS as a treatment option for ICAD and its future prospect.Materials and MethodsWe did the literature review of the key articles and guidelines to elaborate on the role of PTAS in the management of ICAD based on the current data and expert opinion. We searched PubMed, Google Scholar, and Scopus up to August 2020, and included articles published only in the English language.ResultsSince the publication of the results from SAMMPRIS and VISSIT trials, stenting is no longer recommended for secondary stroke prevention in patients with symptomatic ICAD. However, recent clinical studies on intracranial stenting for a subgroup of ICAD patients have shown promising results, likely due to better patient selection and continued advancement of endovascular techniques.ConclusionThere exists a lack of consensus regarding the best endovascular treatment approach (e.g., angioplasty alone or balloon mounted stent vs. self-expanding stent with or without prior angioplasty) or management of in-stent restenosis. Another area of clinical controversy relates to the ideal use and duration of antiplatelet therapy. 相似文献
22.
Lei Mingxi Varghese Bino Hwang Darryl Cen Steven Lei Xiaomeng Desai Bhushan Azadikhah Afshin Oberai Assad Duddalwar Vinay 《Journal of digital imaging》2021,34(5):1156-1170
Journal of Digital Imaging - The image biomarkers standardization initiative (IBSI) was formed to address the standardization of extraction of quantifiable imaging metrics. Despite its effort,... 相似文献
23.
Markus J. Hofer MD Jochen Rohlfs MD Afshin Teymoortash MD Axel Pagenstecher MD 《Brain pathology (Zurich, Switzerland)》2013,23(1):105-108
Malignant tumors with neuroendocrine differentiation of the nasal cavity include neuroendocrine carcinoma, small cell undifferentiated carcinoma, olfactory neuroblastoma (esthesioneuroblastoma), and sinonasal undifferentiated carcinoma (SNUC). The rarity of these tumors and overlapping clinical, histological and immunohistochemical findings make the correct diagnosis difficult. However accurate diagnosis is critical for therapy and the outcome differs significantly between these entities. Here we describe the case of a 62‐year‐old woman with an intranasal tumor extending into the adjacent anatomical compartments and with infiltration of the meninges. The suspected preoperative diagnosis was olfactory neuroblastoma. Histological and immunohistochemical analysis showed a lobulated tumor with neuroendocrine differentiation and we ultimately diagnosed the process as a SNUC. In this report, we discuss the differential diagnosis at hand and present histological findings found in the specimen indicating that the process originated from local glands present in the nasal mucosa. 相似文献
24.
25.
26.
27.
28.
Patrick Jaminet M.D. David Köhler Ph.D. Afshin Rahmanian‐Schwarz M.D. Oliver Lotter M.D. Alice Mager Michele Fornaro Ph.D. Giulia Ronchi Ph.D. Stefano Geuna Ph.D. Peter Rosenberger M.D. Ph.D. Hans‐Eberhard Schaller M.D. Ph.D. 《Microsurgery》2013,33(3):216-222
Introduction: In this study, we evaluated the role of the Netrin‐1 receptor UNC5b (Uncoordinated), a neuronal guidance molecule, during peripheral nerve regeneration using the mouse median nerve model. Materials and methods: Using Western blot analysis, we examined the expression changes of UNC5b after transection and microsurgical repair of the mouse median nerve distal to the transection site. We evaluated the histomorphometrical changes and functional recovery of the grasping force after median nerve transection and repair in wild‐type (WT) mice and UNC5b+/? heterozygous mice. Results: In Western blot analysis, we could show a high increase of UNC5b in the nerve segment distal to the injury site at day 14. Histomorphometrical analysis did not show any significant differences between WT animals and heterozygous animals. Using the functional grasping test, we could demonstrate that peripheral nerve regeneration is significantly diminished in heterozygous UNC5b+/? mice. Conclusion: By using the mouse median nerve model in transgenic animals, we demonstrate that the Netrin‐1 receptor UNC5b plays an important role during peripheral nerve regeneration. © 2012 Wiley Periodicals, Inc. Microsurgery, 2013. 相似文献
29.
Mehrdad Mohammadpour Mohaddeseh Behjati Amir Sadeghi Afshin Fassihi 《International wound journal》2013,10(3):260-264
Kojic acid and deferiprone are iron chelators used for skin lightening and iron‐overload treatment, respectively. As iron chelation and free radical scavenging are principal factors for wound healing, it was hypothesised that the local application of these compounds might accelerate wound healing in rats. Ointments of 3%, 6% and 9% of deferiprone and kojic acid were prepared and topical treatment was performed on in vivo wound models for 12 days twice in day for test and control groups. Topical treatment with 3%, 6% and 9% showed significant improvement in wound healing after 4 days (P < 0·001). Topical application of 3% and 6% deferiprone enhanced wound healing after 8 days (P < 0·026 and P < 0·001, respectively). Accelerated wound healing was seen using 3% and 6% deferiprone after 12 days (P = 0·003 and P < 0·001, respectively). DPPH scavenging assay was also performed to compare the antioxidant potencies of kojic acid and deferiprone. Deferiprone had more free radical scavenging power than kojic acid. Generally, deferiprone topical treatment, accelerated wound healing more than kojic acid because of its higher antioxidant and iron chelation abilities. 相似文献
30.